RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Bellaire, TX · Fort Worth, TX · Garland, TX · +57 more sites
Crohn's Disease clinical trials in Lubbock, TX
11 recruiting crohn's disease studies with a site in Lubbock, TX.
RecruitingPhase 4NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Sponsor: Takeda
El Paso, TX · Georgetown, TX · Houston, TX · +98 more sites
RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · Denton, TX · +84 more sites
RecruitingPhase 3NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Sponsor: Merck Sharp & Dohme LLC
Garland, TX · Lubbock, TX · +9 more sites
RecruitingPhase 3NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Dallas, TX · Fort Worth, TX · Garland, TX · +58 more sites
RecruitingPhase 2NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Sponsor: AbbVie
Cedar Park, TX · El Paso, TX · Garland, TX · +61 more sites
RecruitingPhase 3NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Janssen Research & Development, LLC
Carrollton, TX · Dallas, TX · Lubbock, TX · +36 more sites
RecruitingPhase 3NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Sanofi
Baytown, TX · Dallas, TX · Harlingen, TX · +122 more sites
RecruitingPhase 3NCT07184944
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Sanofi
Lubbock, TX · Mesquite, TX · San Antonio, TX · +31 more sites
RecruitingPhase 4NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Sponsor: Takeda
Cedar Park, TX · Dallas, TX · Houston, TX · +38 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Dallas, TX · Garland, TX · Georgetown, TX · +43 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.